Trump secures immense win as AstraZeneca joins Pfizer in chopping US drug costs

president Donald Trump secured a serious victory on Friday when AstraZeneca agreed to decrease prescription drug costs for Medicaid – a spin that follows an identical settlement from Pfizer and represents a key level in the federal government’s push for more cost-effective medication.

Accordingly APThe settlement, launched throughout an occasion within the Oval Workplace on the White Home, commits AstraZeneca to MFN pricing for Medicaid.

This implies the corporate can compete with the bottom drug costs in different rich nations.

Trump celebrated the deal, saying it may outcome in U.S. costs being “the bottom costs on the earth.”

AstraZeneca CEO Pascal Soriot accompanied Trump on the announcement. He later admitted satirically that the negotiations had been intense: the president and his crew “actually saved me up at evening.”

Beneath the unique settlement, AstraZeneca can even assure the pricing customary for newly launched medication.

This spin follows Pfizer’s latest settlement with the federal government. Each agreements are primarily based on an government order signed by Trump in Could: Drugmakers have been given the possibility to voluntarily decrease costs or face stricter caps on the quantities the federal government would pay.

BREAKING: Trump simply introduced that AstraZeneca, the biggest drugmaker in the UK, will make investments $50 billion in america over the subsequent 5 years.

They can even promote their medication to People by way of “TrumpRX” at preferential nation costs.

GREAT! pic.twitter.com/g5gv76UWR7

– George (@BehizyTweets) October 10, 2025

Trump touts AstraZeneca’s $4.5 billion deal

Trump criticized AstraZeneca’s preliminary resistance, quipping: “The tariffs have been a immense motive he got here right here.”

The president additionally highlighted AstraZeneca’s dedication to increasing manufacturing within the U.S. by saying a unique $4.5 billion manufacturing facility in Virginia, simply piece of a $50 billion funding draw by way of 2030.

This facility alone is predicted to create round 3,600 jobs within the USA.

AstraZeneca, primarily based in Cambridge, U.Okay., produces medication reminiscent of Tagrisso for lung most cancers, Lynparza for ovarian most cancers and Calquence for leukemia – and had gross sales of greater than $7.5 billion within the U.S. final 12 months.

Whereas the bulletins have been met with reward from drug value advocates, some consultants warn that pinning all hope on drug makers could possibly be dangerous until they’re supported by more durable U.S. insurance policies.

Questions stay as to how a lot sufferers and states will truly profit, since Medicaid already secures a “greatest worth” contract and most sufferers enact not pay the complete value out of pocket. CBS Information reported.

Trump additionally unveiled a unique initiative: an internet site referred to as TrumpRx.gov, scheduled to launch in January 2026.

Sufferers can utilize the web site to order medicines straight from Roche and AstraZeneca at diminished money costs.